A new deal struck by the Africa CDC and the European Commission includes facilitating R&D into new health products and promoting technology transfer in Africa.
The Africa Centres for Disease Control and Prevention (Africa CDC) and the European Commission have signed an agreement to support access to health products and strengthen local manufacturing in Africa.
Part of the “Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines, and Health Technologies,” the new deal includes facilitating R&D into new health products and promoting technology transfer, “with a focus on local
Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.
Drugmakers are not expecting a big financial hit from tariffs for now, but a report commissioned by the industry trade association PhRMA suggests a potentially steep cost for pharma-sector tariffs.
Aragen’s CEO Manni Kantipudi, who is keenly watching the Trump Administration’s moves on pharma tariffs, discusses funding cuts at the National Institutes of Health, big pharma’s US onshoring moves, and talks with the Indian government to solve intellectual property challenges in an interview.
Alonza Cruse, director of the Office of Human and Animal Drugs Inspectorate, and two other senior inspection officials are departing, along with Mark Raza, chief counsel from 2021 until January.
